280 likes | 548 Views
2. Malaria Diagnosis, WHO 2009. Prompt parasitological confirmation by microscopy or alternatively by RDTs is recommended in all patients suspected of malaria before treatment is started. Treatment solely on the basis of clinical suspicion should only be considered when a parasitological diagnosis
E N D
1. 1 Malaria diagnosis: Moving from a mess to an ordered programme to a tool for eliminationThe All-Party Parliamentary Group on Malaria and Neglected Tropical Diseases (APPMG)
David Bell
FIND
Nov 2009
2. 2 Malaria Diagnosis, WHO 2009 Prompt parasitological confirmation by microscopy or alternatively by RDTs is recommended in all patients suspected of malaria before treatment is started.
Treatment solely on the basis of clinical suspicion should only be considered when a parasitological diagnosis is not accessible.
3. 3 Confirmation of diagnosis % confirmation of parasitaemia in suspected malaria cases
4. 4 Magnitude of over-diagnosis /over-treatment
5. 5 Changing case managementManagement of febrile illness
6. 6
7. 7 RDT impact, Zambia
8. 8
9. 9 Senegal Parasite prevalence of malaria-like fever cases
10. 10 Weekly Malaria Lab. Tests, 2008, Kabale District: Uganda Saving costs by treating only lab confirmed case!
11. 11
12. 12 Challenges to implementing comprehensive RDT-based diagnosis Sensitivity e.g. 20% to 99% in published studies
Stability
Recommended storage temperature often inappropriate for rural health clinic in tropics (e.g. <35°C)
User safety
Blood safety (gloves, sharps disposal, HIV risk)
Programmatic
Managing negative results (non-malaria fever patients)
Logistics
Monitoring
13. 13 Building a structured diagnostics programme
14. 14 Selecting RDTs for procurement.WHO Product Testing Round 1: 2008-9
15. 15
16. 16 WHO-FIND Laboratory network
17. 17 Innovative planning, infrastructure and training
18. 18
19. 19 Minimum standard for funding a programme?
20. 20 In the pipeline 2010-2011:Country based lot-testing, clinic-based QC testing Recombinant antigen-based testing panels for RDTs:
Moving control of quality control to national programmes, and health workers, in endemic countries
Harmonizing standards and RDT detection thresholds between developers, manufacturers and users
21. 21 Towards elimination: Detection of P. falciparum ‘reservoir’
22. 22
23. 23 Potential for high through-put LAMP-based screening
24. 24 Accurate diagnosis at community level: Effort and outcomes
25. 25 WHO
FIND
HTD, UK
RITM, Philippines
IP, Cambodia
US CDC
AMI, Australia
MSF
DMR, Myanmar
IP, Madagascar
IP, Central African Republic
IHDRC, Tanzania
KEMRI, Kenya
EHNRI, Ethiopia
Uni Lagos, Nigeria
UCAD, Senegal
CIDEIM, Colombia
IMT, Peru
Zambia NMCC
Uganda MoH
URC
Malaria Consortium
NBI, South Africa
BMGF
USAID/Asia
USAID/Deliver
AusAID
Manufacturers
26. 26 Addressing microscopy performance
27. 27 Introduction of a slide validation programme (MSF, Sudan)
28. 28 Addressing microscopy performance